International Liver Congress

Meeting News

Epclusa achieves best SVR rates in patients with HCV genotype 3

April 16, 2019
VIENNA — Patients with hepatitis C genotype 3 and compensated cirrhosis had higher rates of sustained virologic response after treatment with…
Meeting NewsVideo

VIDEO: Plasma shows impact of Middle Eastern diet on microbiome

April 16, 2019
VIENNA — In this exclusive video from the International Liver Congress 2019, Bajaj S. Jasmohan, MD, from the Virginia Commonwealth University…
Meeting News

Core protein inhibitor, nuc combination shows promise in HBV

April 13, 2019
VIENNA — A combination of a core protein inhibitor and nucleos(t)ide analogue therapy brought hepatitis B virus RNA and DNA below levels of…
Meeting News

Elafibranor shows anticholestatic effect in PBC

April 13, 2019
VIENNA — When patients do not fully respond to ursodeoxycholic acid, a new peroxisome proliferator-activated receptor alpha and delta agonist…
Meeting News

Emricasan reduces portal pressure in cirrhosis despite missing endpoint

April 13, 2019
VIENNA — Emricasan missed its primary endpoint of hepatic venous pressure gradient reduction in all patients with nonalcoholic…
Meeting NewsVideo

VIDEO: Physicians must nurture the engaged patient

April 13, 2019
VIENNA — In this exclusive video from the International Liver Congress 2019, Wayne Eskridge, founder and CEO of the Fatty Liver Foundation…
Meeting News

Givosiran offers hope for acute hepatic porphyria recurrent attacks

April 13, 2019
VIENNA — An “exciting, novel RNAi therapy” significantly lowered acute hepatic porphyria recurrent attacks, according to data…
Meeting News

FMT capsules treat encephalopathy: ‘The way to the brain is through the gut’

April 13, 2019
VIENNA — Fecal microbiota transplant, delivered via capsule, lessened hospitalizations for patients with hepatic encephalopathy while improving…
Meeting News

Combo therapy nears ‘curative’ levels in HBV/HDV coinfection

April 13, 2019
VIENNA — A combination of Myrcludex with interferon produced undetectable levels of hepatitis D and significant lowering of hepatitis B virus…
Meeting NewsVideo

VIDEO: Ocaliva shows long-term effects on immune, inflammatory markers

April 13, 2019
VIENNA — In this exclusive video from the International Liver Congress 2019, Gideon M. Hirschfield, MD, from the Toronto Center for Liver…